Beijing, China 1/15/14; Beijing, China 1/20/14; Washington, DC 1/31/14— Thermo Fisher Scientific’s proposed acquisition of Life Technologies (see IBO 4/15/13) has received clearance in the US and China. Stating that the merger would have restricted competition in the cell culture products, sequence-specific primer (SSP) kits, protein standards for SDS-PAGE and siRNA reagent markets, China’s Ministry […]
South San Francisco and Sunnyvale, CA 1/29/14—Fluidigm has definitely agreed to acquire DVS Sciences, a provider of multiparameter single-cell protein analysis systems, for $207.5 million in stock and cash. DVS’s mass cytometry technology includes the CyTOF 2 Mass Cytometer, which analyzers antibody/metal complexes using atomic MS. “We believe the acquisition of DVS will increase Fluidigm’s […]
Vélizy-Villacoublay, France and San Diego, CA 1/30/14—Dassault Systèmes, a publicly held 3-D design software company, has signed a definitive agreement to acquire Accelrys, a provider of scientific innovation lifecycle management software. Dassault will make an all cash tender offer for Accelys’s outstanding shares at a price of $12.50 per share, a 28.6% premium over the […]
Thermo and Life The pending merger (see IBO 4/15/13) will create an industry behemoth and creates new challenges for competitors, such as those in the lab distribution market. It also will provide Thermo with a commanding position as a supplier to pharmaceutical and biotechnology companies for both instruments and consumables. The integration process will be […]
Milwaukee, WI 1/3/14—ChemWare, a provider of information management systems to lab markets, has been acquired by Dohmen, an outsourced services company for health care. In addition to ChemWare, Dohmen also announced the acquisitions of Red Arrow Labs and Clinical Path Consulting. “Our life science and healthcare clients are increasingly interested in using technology to connect […]
Brussels, Belgium 1/9/14—Food and pharmaceutical lab services firm Eurofins has agreed to acquire Merck Millipore’s (EMD Millipore in the US and Canada) Discovery and Development Solutions business (DDS) for an undisclosed amount. DDS provides bioanalytical testing and early-state discovery services and products to the biopharmaceutical market, including discovery pharmacology services and bioanalytical testing to support […]
Chalfont St. Giles, England 1/6/13; Waltham, MA 1/6/13—GE Healthcare’s Life Sciences division has agreed to acquire Thermo Fisher Scientific’s cell culture media and sera, and gene modulation and magnetic bead businesses for $1.06 billion. The businesses’ estimated combined 2013 revenues were $250 million. The sale of the businesses was required by the EU for approval […]
New York, NY 12/19/13; San Francisco, CA 12/19/13—Certara, a provider of model-based drug development and data analytics software and consulting services, has been sold by Vector Capital to Arsenal Capital Partners. Financial details were not provided. Certara’s solutions cover the discovery, preclinical and clinical stages of drug development. “Technology-driven informatics models will not only result […]
Port Washington, NY 12/23/13; Danbury, CT 12/23/13—Filtration and separation firm Pall has agreed to acquire ATMI Life Sciences from ATMI, a provider of specialty semiconductor materials, for $185 million. ATMI Life Sciences provides single-use process systems and consumables for the pharmaceutical and biopharmaceutical industries. “This acquisition immediately strengthens our offering and broadens our already extensive […]
Bonaduz, Switzerland 12/9/13—Hamilton has announced the acquisition of the Biotech sensors business of Fogale Nanotech for an undisclosed amount. The Biotech business provides biomass sensors that use the dielectric properties of living cells. The sensors are used for online monitoring for bioprocess optimization and control. “Fogale’s biomass sensors are the ideal addition to our product […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
